InI logo.png

9-10 November 2021 | Live virtual conference

Join other impactful investors and meet the most vibrant start-ups reinventing our health

Invest in the best innovators

We carefully select the most promising founders of pre-seed to Series A start-ups to match our calibre influential VCs, angel investors, HNWIs and family offices participants.

From 1-on-1 partnering, roundtables and practical insights into emerging trends and opportunities emerging in the Barcelona ecosystem; our concise 2-day virtual programme will foster valued relationships and drive future collaborations.

Secure
Dealflow

We gather and validate the most promising start-ups in the health-tech, med-tech and biotech space. Match with relevant ventures which align with your investment thesis.

Investor Meetings

We offer exclusive opportunities to network with other VCs, angel investors, high net worths and family offices to share ideas and potential co-investing opportunities.

Stay
Informed

Keep up to date with up and coming trends across the life science and health tech sectors from the early inventors to industry influencers.

Gradient.png
APPLY FOR INVESTOR ACCREDITATION

Accredited investors are eligible for FREE tickets and the opportunity to be featured alongside some of the top firms in this sector.

 

Please enter your details below to enquire about our exclusive benefits for qualified investors.

 

Applications to investors accreditation are subject to our Investor Accreditation policy

arrow&v
arrow&v

Thanks for your interest in our event!​ Your application has been submitted successfully and our investors team will get back to you shortly.

Meet some attending investors
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Group 4 (1).png
Gradient.png
Hermann-NEW-WEBSITE.jpg

I was blown away! I am so impressed that there are so many good companies now

Dr Hermann Hauser
Founder & Director at Amadeus Capital Partners